OBIO icon

Orchestra BioMed

24 hedge funds and large institutions have $56.6M invested in Orchestra BioMed in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$748K
2 +$649K
3 +$267K
4
RL
RPO LLC
Connecticut
+$35.5K

Top Sellers

1 -$1.5M
2 -$387K
3 -$28K
4
Citadel Advisors
Citadel Advisors
Florida
-$13.5K
5
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.98M
2
$7.89M
3
$6.85M
4
$6.09M
5
$3.99M
6
$3.99M
7
$3.92M
8
$2.5M
9
$2.5M
10
$2.45M
11
$1.7M
12
$1.26M
13
$748K
14
$649K
15
$498K
16
$463K
17
$277K
18
$267K
19
$199K
20
$150K
21
$124K
22
$99.8K
23
$21K
24
$15.4K
25